This interaction may underlie the pathological conditions in which abnormalities of beta-catenin signaling have been implicated.[17] In tumor cells, expression of ER down regulates beta-catenin and its target genes, cyclin D1 and Rb, important regulators of cell cycle and cell proliferation. Here, RB1 is linked to neoplasm.